SlideShare una empresa de Scribd logo
1 de 11
Find Industry reports, Company profiles
ReportLinker                                                                       and Market Statistics
                                             >> Get this Report Now by email!



Chemotherapy Effects ' Pipeline Review, H1 2013
Published on February 2013

                                                                                                             Report Summary

Chemotherapy Effects ' Pipeline Review, H1 2013


Summary


Global Markets Direct's, 'Chemotherapy Effects - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic development for Chemotherapy Effects, complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for
Chemotherapy Effects. Chemotherapy Effects - Pipeline Review, Half Year is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.


Scope


- A snapshot of the global therapeutic scenario for Chemotherapy Effects.
- A review of the Chemotherapy Effects products under development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chemotherapy Effects pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.


Reasons to buy


- Identify and understand important and diverse types of therapeutics under development for Chemotherapy Effects.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive
advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Chemotherapy Effects pipeline depth and focus of Indication
therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.




Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                                                   Page 1/11
Find Industry reports, Company profiles
ReportLinker                                                                    and Market Statistics
                                             >> Get this Report Now by email!



                                                                                                 Table of Content

Table of Contents


Table of Contents 2
List of Tables 8
List of Figures 10
Introduction 11
Global Markets Direct Report Coverage 11
Chemotherapy Effects Overview 12
Therapeutics Development 13
An Overview of Pipeline Products for Chemotherapy Effects 13
Chemotherapy Effects Therapeutics under Development by Companies 15
Chemotherapy Effects Therapeutics under Investigation by Universities/Institutes 22
Late Stage Products 24
Comparative Analysis 24
Mid Clinical Stage Products 25
Comparative Analysis 25
Early Clinical Stage Products 26
Comparative Analysis 26
Discovery and Pre-Clinical Stage Products 27
Comparative Analysis 27
Chemotherapy Effects Therapeutics ' Products under Development by Companies 28
Chemotherapy Effects Therapeutics ' Products under Investigation by Universities/Institutes 35
Companies Involved in Chemotherapy Effects Therapeutics Development 36
Kyowa Hakko Kirin Co., Ltd. 36
Amgen Inc. 37
Adherex Technologies Inc. 38
Eli Lilly and Company 39
BioDelivery Sciences International, Inc. 40
Merck & Co., Inc. 41
Lentigen Corporation 42
Reliance Life Sciences Pvt. Ltd. 43
A.P. Pharma, Inc. 44
Aphios Corporation 45
Axcan Pharma Inc. 46
Dong-A Pharmaceutical Co., Ltd. 47
Dr. Reddy's Laboratories Limited 48
Maxygen, Inc. 49
Sigma-Tau S.p.A. 50
Teva Pharmaceutical Industries Limited 51
Sandoz Inc. 52
CEL-SCI Corporation 53
Zosano Pharma, Inc. 54
3SBio Inc. 55
EpiCept Corporation 56



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                           Page 2/11
Find Industry reports, Company profiles
ReportLinker                                                                and Market Statistics
                                             >> Get this Report Now by email!

Hana Biosciences, Inc. 57
IntelGenx Technologies Corp. 58
NovaDel Pharma, Inc. 59
La Jolla Pharmaceutical Company 60
Telik, Inc. 61
Mundipharma International Limited 62
Cerbios-Pharma SA 63
ProMetic Life Sciences Inc. 64
Lipoxen PLC 65
LG Life Sciences, Ltd 66
Diamyd Medical AB 67
Pluristem Therapeutics Inc. 68
DARA BioSciences, Inc. 69
LTT Bio-Pharma Co., Ltd. 70
Uni-Bio Science Group Ltd. 71
ProStrakan Group plc 72
Teikoku Pharma USA, Inc. 73
SymBio Pharmaceuticals Limited 74
Cellerant Therapeutics, Inc. 75
Spectrum Pharmaceuticals, Inc. 76
INSYS Therapeutics, Inc. 77
Pharmagenesis, Inc. 78
Neurotune AG 79
Med Discovery SA 80
Helsinn Healthcare S.A. 81
Wellstat Therapeutics Corporation 82
Ventria Bioscience 83
PledPharma AB 84
Tranzyme Pharma, Inc. 85
Indus Biotech Private Limited 86
Synageva BioPharma Corp. 87
Phage Biotechnology Corporation 88
Inimex Pharmaceuticals, Inc. 89
Bolder Biotechnology, Inc. 90
Shin Nippon Biomedical Laboratories, Ltd. 91
Welichem Biotech Inc. 92
Sound Pharmaceuticals, Inc. 93
SpePharm Holding B.V. 94
Biothera 95
Avesthagen Limited 96
Spinifex Pharmaceuticals Pty Limited 97
Tosk, Inc. 98
Almac Discovery Ltd. 99
Pfenex Inc. 100
Mycenax Biotech Inc. 101
Therapure Biopharma Inc. 102
Eurofarma 103
Neumedicines Inc. 104



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                      Page 3/11
Find Industry reports, Company profiles
ReportLinker                                                                and Market Statistics
                                             >> Get this Report Now by email!

Applied Protein Sciences, LLC 105
Acacia Pharma Ltd. 106
Advancell 107
Chemotherapy Effects ' Therapeutics Assessment 108
Assessment by Monotherapy Products 108
Assessment by Combination Products 109
Assessment by Route of Administration 110
Assessment by Molecule Type 112
Drug Profiles 115
Romiplostim - Drug Profile 115
rolapitant hydrochloride - Drug Profile 117
MAXY-G34 - Drug Profile 118
sodium thiosulfate - Drug Profile 120
menadione - Drug Profile 122
ondansetron MR - Drug Profile 123
granisetron - Drug Profile 124
MDPK-67b - Drug Profile 125
NT-13317 - Drug Profile 127
ondansetron hydrochloride - Drug Profile 128
Multikine - Drug Profile 129
TZP-201 - Drug Profile 131
dronabinol - Drug Profile 132
Slow-Release G-CSF - Drug Profile 133
KRN-5500 - Drug Profile 134
NuPIAO - Drug Profile 136
granisetron - Drug Profile 137
granisetron - Drug Profile 138
(amitriptyline + ketamine) - Drug Profile 140
ondansetron CR - Drug Profile 141
ezatiostat hydrochloride - Drug Profile 142
Pegylated GCSF - Drug Profile 144
LG-631 - Drug Profile 145
filgrastim - Drug Profile 147
ZP-1846 - Drug Profile 148
PBI-1402 - Drug Profile 149
balugrastim - Drug Profile 150
INDUS-82020 - Drug Profile 152
leteprinim - Drug Profile 153
PHY-626 - Drug Profile 154
PHY-777 - Drug Profile 155
ErepoXen - Drug Profile 156
IMX-942 - Drug Profile 157
GCS-100 - Drug Profile 158
CLT-008 - Drug Profile 160
GranNEX - Drug Profile 161
granisetron - Drug Profile 162
Dexamethasone + Granisetron + Prochlorperazine - Drug Profile 163
F-511 cream - Drug Profile 165



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                      Page 4/11
Find Industry reports, Company profiles
ReportLinker                                                                     and Market Statistics
                                             >> Get this Report Now by email!

filgrastim - Drug Profile 166
pegfilgrastim - Drug Profile 167
levocarnitine - Drug Profile 168
buprenorphine hydrochloride - Drug Profile 169
pegfilgrastim - Drug Profile 170
MTP-131 - Drug Profile 171
lipegfilgrastim - Drug Profile 173
darbepoetin alfa - Drug Profile 174
LY-2787106 - Drug Profile 175
dexrazoxane - Drug Profile 176
palonosetron hydrochloride - Drug Profile 177
ATH-008 - Drug Profile 178
droperidol - Drug Profile 179
CR-3294 - Drug Profile 180
uridine triacetate - Drug Profile 181
TPW-146 - Drug Profile 183
EMA-401 - Drug Profile 184
SPI-1005 - Drug Profile 186
ebselen - Drug Profile 188
granisetron - Drug Profile 189
WBI-2100 + [cisplatin] - Drug Profile 190
WBI-2100 + [gemcitabine hydrochloride] - Drug Profile 191
WBI-2100 + [dacarbazine] - Drug Profile 192
WBI-2100 + [paclitaxel] - Drug Profile 193
(netupitant + palonosetron hydrochloride) - Drug Profile 194
NMIL12-1 - Drug Profile 196
dexamethasone acetate + [palonosetron hydrochloride] - Drug Profile 198
PanCyte - Drug Profile 199
erythropoietin biosimilar - Drug Profile 200
APD-403 - Drug Profile 201
NT-24336 - Drug Profile 202
UNI-rhIL-11 - Drug Profile 203
TBI-304 - Drug Profile 204
BBT-015 - Drug Profile 205
BBT-018 - Drug Profile 206
IRX-4310 - Drug Profile 207
Imprime PGG - Drug Profile 208
5HT3 receptor antagonist + [dexamethasone ] + [fosaprepitant dimeglumine] - Drug Profile 210
filgrastim - Drug Profile 211
aprepitant - Drug Profile 212
granisetron - Drug Profile 213
filgrastim - Drug Profile 215
darbepoetin alfa - Drug Profile 216
budesonide - Drug Profile 217
Plasmid Gene Therapy For Chemotherapy-Induced Thrombocytopenia - Drug Profile 218
carbamazepine - Drug Profile 219
Filgrastim Biosimilar - Drug Profile 220
F-627 - Drug Profile 221



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                           Page 5/11
Find Industry reports, Company profiles
ReportLinker                                                                and Market Statistics
                                             >> Get this Report Now by email!

palonosetron hydrochloride New Formulation - Drug Profile 222
dronabinol Intavenous - Drug Profile 223
PLX-BMP - Drug Profile 224
calcitriol - Drug Profile 227
INT-0010 - Drug Profile 228
PLED-mangafodipir trisodium - Drug Profile 229
NN1 Neurotrophin - Drug Profile 231
erythromycin - Drug Profile 232
AK-295 - Drug Profile 233
NecroX-7 - Drug Profile 234
amisulpride - Drug Profile 235
VEN-101 - Drug Profile 236
TK-112690 - Drug Profile 237
filgrastim Biosimilar - Drug Profile 238
pegfilgrastim Biosimilar - Drug Profile 239
AP-002 - Drug Profile 240
Prostaglandin E2 - Drug Profile 241
TheraPhil - Drug Profile 242
PG2-2000 - Drug Profile 243
granisetron - Drug Profile 244
SHIP1 Inhibitors - Drug Profile 245
Apoptosis Inhibitors - Drug Profile 246
Chemotherapy Effects Therapeutics ' Drug Profile Updates 247
Chemotherapy Effects Therapeutics ' Discontinued Products 283
Chemotherapy Effects Therapeutics - Dormant Products 284
Chemotherapy Effects ' Product Development Milestones 288
Featured News & Press Releases 288
Appendix 294
Methodology 294
Coverage 294
Secondary Research 294
Primary Research 294
Expert Panel Validation 294
Contact Us 295
Disclaimer 295




List of Tables


Number of Products Under Development for Chemotherapy Effects, H1 2013 20
Products under Development for Chemotherapy Effects ' Comparative Analysis, H1 2013 21
Number of Products under Development by Companies, H1 2013 23
Number of Products under Development by Companies, H1 2013 (Contd..1) 24
Number of Products under Development by Companies, H1 2013 (Contd..2) 25
Number of Products under Development by Companies, H1 2013 (Contd..3) 26
Number of Products under Development by Companies, H1 2013 (Contd..4) 27
Number of Products under Development by Companies, H1 2013 (Contd..5) 28



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                      Page 6/11
Find Industry reports, Company profiles
ReportLinker                                                                    and Market Statistics
                                             >> Get this Report Now by email!

Number of Products under Investigation by Universities/Institutes, H1 2013 30
Comparative Analysis by Late Stage Development, H1 2013 31
Comparative Analysis by Mid Clinical Stage Development, H1 2013 32
Comparative Analysis by Early Clinical Stage Development, H1 2013 33
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013 34
Products under Development by Companies, H1 2013 35
Products under Development by Companies, H1 2013 (Contd..1) 36
Products under Development by Companies, H1 2013 (Contd..2) 37
Products under Development by Companies, H1 2013 (Contd..3) 38
Products under Development by Companies, H1 2013 (Contd..4) 39
Products under Development by Companies, H1 2013 (Contd..5) 40
Products under Development by Companies, H1 2013 (Contd..6) 41
Products under Investigation by Universities/Institutes, H1 2013 42
Kyowa Hakko Kirin Co., Ltd., H1 2013 43
Amgen Inc., H1 2013 44
Adherex Technologies Inc., H1 2013 45
Eli Lilly and Company, H1 2013 46
BioDelivery Sciences International, Inc., H1 2013 47
Merck & Co., Inc., H1 2013 48
Lentigen Corporation, H1 2013 49
Reliance Life Sciences Pvt. Ltd., H1 2013 50
A.P. Pharma, Inc., H1 2013 51
Aphios Corporation, H1 2013 52
Axcan Pharma Inc., H1 2013 53
Dong-A Pharmaceutical Co., Ltd., H1 2013 54
Dr. Reddy's Laboratories Limited, H1 2013 55
Maxygen, Inc., H1 2013 56
Sigma-Tau S.p.A., H1 2013 57
Teva Pharmaceutical Industries Limited, H1 2013 58
Sandoz Inc., H1 2013 59
CEL-SCI Corporation, H1 2013 60
Zosano Pharma, Inc., H1 2013 61
3SBio Inc., H1 2013 62
EpiCept Corporation, H1 2013 63
Hana Biosciences, Inc., H1 2013 64
IntelGenx Technologies Corp., H1 2013 65
NovaDel Pharma, Inc., H1 2013 66
La Jolla Pharmaceutical Company, H1 2013 67
Telik, Inc., H1 2013 68
Mundipharma International Limited, H1 2013 69
Cerbios-Pharma SA, H1 2013 70
ProMetic Life Sciences Inc., H1 2013 71
Lipoxen PLC, H1 2013 72
LG Life Sciences, Ltd, H1 2013 73
Diamyd Medical AB, H1 2013 74
Pluristem Therapeutics Inc., H1 2013 75
DARA BioSciences, Inc., H1 2013 76
LTT Bio-Pharma Co., Ltd., H1 2013 77



Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                          Page 7/11
Find Industry reports, Company profiles
ReportLinker                                                                 and Market Statistics
                                             >> Get this Report Now by email!

Uni-Bio Science Group Ltd., H1 2013 78
ProStrakan Group plc, H1 2013 79
Teikoku Pharma USA, Inc., H1 2013 80
SymBio Pharmaceuticals Limited, H1 2013 81
Cellerant Therapeutics, Inc., H1 2013 82
Spectrum Pharmaceuticals, Inc., H1 2013 83
INSYS Therapeutics, Inc., H1 2013 84
Pharmagenesis, Inc., H1 2013 85
Neurotune AG, H1 2013 86
Med Discovery SA, H1 2013 87
Helsinn Healthcare S.A., H1 2013 88
Wellstat Therapeutics Corporation, H1 2013 89
Ventria Bioscience, H1 2013 90
PledPharma AB, H1 2013 91
Tranzyme Pharma, Inc., H1 2013 92
Indus Biotech Private Limited, H1 2013 93
Synageva BioPharma Corp., H1 2013 94
Phage Biotechnology Corporation, H1 2013 95
Inimex Pharmaceuticals, Inc., H1 2013 96
Bolder Biotechnology, Inc., H1 2013 97
Shin Nippon Biomedical Laboratories, Ltd., H1 2013 98
Welichem Biotech Inc., H1 2013 99
Sound Pharmaceuticals, Inc., H1 2013 100
SpePharm Holding B.V., H1 2013 101
Biothera, H1 2013 102
Avesthagen Limited, H1 2013 103
Spinifex Pharmaceuticals Pty Limited, H1 2013 104
Tosk, Inc., H1 2013 105
Almac Discovery Ltd., H1 2013 106
Pfenex Inc., H1 2013 107
Mycenax Biotech Inc., H1 2013 108
Therapure Biopharma Inc., H1 2013 109
Eurofarma, H1 2013 110
Neumedicines Inc., H1 2013 111
Applied Protein Sciences, LLC, H1 2013 112
Acacia Pharma Ltd., H1 2013 113
Advancell, H1 2013 114
Assessment by Monotherapy Products, H1 2013 115
Assessment by Combination Products, H1 2013 116
Assessment by Stage and Route of Administration, H1 2013 118
Assessment by Stage and Molecule Type, H1 2013 121
Chemotherapy Effects Therapeutics ' Drug Profile Updates 254
Chemotherapy Effects Therapeutics ' Discontinued Products 290
Chemotherapy Effects Therapeutics ' Dormant Products 291
Chemotherapy Effects Therapeutics ' Dormant Products (Contd..1) 292
Chemotherapy Effects Therapeutics ' Dormant Products (Contd..2) 293
Chemotherapy Effects Therapeutics ' Dormant Products (Contd..3) 294




Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                       Page 8/11
Find Industry reports, Company profiles
ReportLinker                                                                 and Market Statistics
                                             >> Get this Report Now by email!

List of Figures


Number of Products under Development for Chemotherapy Effects, H1 2013 20
Products under Development for Chemotherapy Effects ' Comparative Analysis, H1 2013 21
Products under Development by Companies, H1 2013 22
Products under Investigation by Universities/Institutes, H1 2013 29
Late Stage Products, H1 2013 31
Mid Clinical Stage Products, H1 2013 32
Early Clinical Stage Products, H1 2013 33
Discovery and Pre-Clinical Stage Products, H1 2013 34
Assessment by Monotherapy Products, H1 2013 115
Assessment by Combination Products, H1 2013 116
Assessment by Route of Administration, H1 2013 117
Assessment by Stage and Route of Administration, H1 2013 118
Assessment by Molecule Type, H1 2013 119
Assessment by Stage and Molecule Type, H1 2013 120




Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                       Page 9/11
Find Industry reports, Company profiles
ReportLinker                                                                             and Market Statistics
                                             >> Get this Report Now by email!
              Fax Order Form
              To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                          Europe, Middle East and Africa : + 33 4 37 37 15 56
                          Asia, Oceania and America : + 1 (805) 617 17 93
              If you have any questions please visit http://www.reportlinker.com/notify/contact


              Order Information
              Please verify that the product information is correct and select the format(s) you require.

                    Chemotherapy Effects ' Pipeline Review, H1 2013




              Product Formats
              Please select the product formats and the quantity you require.

                                     1 User License--USD 2 000.00               Quantity: _____



                                     Site License--USD 4 000.00                 Quantity: _____



                                     Corporate License--USD 6 000.00            Quantity: _____




              Contact Information
              Please enter all the information below in BLOCK CAPITALS


              Title:                   Mr                       Mrs    Dr                 Miss              Ms                 Prof

              First Name:                   _____________________________ Last Name: __________________________________

              Email Address:              __________________________________________________________________________

              Job Title:                  __________________________________________________________________________

              Organization:               __________________________________________________________________________

              Address:                    __________________________________________________________________________

              City:                        __________________________________________________________________________

              Postal / Zip Code:            __________________________________________________________________________

              Country:                    __________________________________________________________________________

              Phone Number:               __________________________________________________________________________

              Fax Number:                 __________________________________________________________________________




Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                                                     Page 10/11
Find Industry reports, Company profiles
ReportLinker                                                                                         and Market Statistics
                                             >> Get this Report Now by email!
              Payment Information
              Please indicate the payment method, you would like to use by selecting the appropriate box.




                     Payment by credit card                         Card Number: ______________________________________________


                                                                    Expiry Date     __________ / _________


                                                                    CVV Number _____________________


                                                                    Card Type (ex: Visa, Amex…) _________________________________




                     Payment by wire transfer                       Crédit Mutuel
                                                                    RIB : 10278 07314 00020257701 89
                                                                    BIC : CMCIFR2A
                                                                    IBAN : FR76 1027 8073 1400 0202 5770 189




                      Payment by check                              UBIQUICK SAS
                                                                    16 rue Grenette – 69002 LYON, FRANCE




                                  Customer signature:

                                   




              Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
              http://www.reportlinker.com/index/terms




                                                                     Please fax this form to:

                                                      Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                         Asia, Oceania and America : + 1 (805) 617 17 93




Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare)                                                                   Page 11/11

Más contenido relacionado

Más de ReportLinker.com

Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy ReportReportLinker.com
 

Más de ReportLinker.com (20)

Project Caf
Project CafProject Caf
Project Caf
 
Project Caf
Project CafProject Caf
Project Caf
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
 
 
 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 
World Biomass Report
World Biomass ReportWorld Biomass Report
World Biomass Report
 
World Biofuels Report
World Biofuels ReportWorld Biofuels Report
World Biofuels Report
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy Report
 
Solar PV Report
Solar PV ReportSolar PV Report
Solar PV Report
 

Chemotherapy Effects ' Pipeline Review, H1 2013

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Chemotherapy Effects ' Pipeline Review, H1 2013 Published on February 2013 Report Summary Chemotherapy Effects ' Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chemotherapy Effects - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Effects, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Effects. Chemotherapy Effects - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Chemotherapy Effects. - A review of the Chemotherapy Effects products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Chemotherapy Effects pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Chemotherapy Effects. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Chemotherapy Effects pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 1/11
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table of Content Table of Contents Table of Contents 2 List of Tables 8 List of Figures 10 Introduction 11 Global Markets Direct Report Coverage 11 Chemotherapy Effects Overview 12 Therapeutics Development 13 An Overview of Pipeline Products for Chemotherapy Effects 13 Chemotherapy Effects Therapeutics under Development by Companies 15 Chemotherapy Effects Therapeutics under Investigation by Universities/Institutes 22 Late Stage Products 24 Comparative Analysis 24 Mid Clinical Stage Products 25 Comparative Analysis 25 Early Clinical Stage Products 26 Comparative Analysis 26 Discovery and Pre-Clinical Stage Products 27 Comparative Analysis 27 Chemotherapy Effects Therapeutics ' Products under Development by Companies 28 Chemotherapy Effects Therapeutics ' Products under Investigation by Universities/Institutes 35 Companies Involved in Chemotherapy Effects Therapeutics Development 36 Kyowa Hakko Kirin Co., Ltd. 36 Amgen Inc. 37 Adherex Technologies Inc. 38 Eli Lilly and Company 39 BioDelivery Sciences International, Inc. 40 Merck & Co., Inc. 41 Lentigen Corporation 42 Reliance Life Sciences Pvt. Ltd. 43 A.P. Pharma, Inc. 44 Aphios Corporation 45 Axcan Pharma Inc. 46 Dong-A Pharmaceutical Co., Ltd. 47 Dr. Reddy's Laboratories Limited 48 Maxygen, Inc. 49 Sigma-Tau S.p.A. 50 Teva Pharmaceutical Industries Limited 51 Sandoz Inc. 52 CEL-SCI Corporation 53 Zosano Pharma, Inc. 54 3SBio Inc. 55 EpiCept Corporation 56 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 2/11
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Hana Biosciences, Inc. 57 IntelGenx Technologies Corp. 58 NovaDel Pharma, Inc. 59 La Jolla Pharmaceutical Company 60 Telik, Inc. 61 Mundipharma International Limited 62 Cerbios-Pharma SA 63 ProMetic Life Sciences Inc. 64 Lipoxen PLC 65 LG Life Sciences, Ltd 66 Diamyd Medical AB 67 Pluristem Therapeutics Inc. 68 DARA BioSciences, Inc. 69 LTT Bio-Pharma Co., Ltd. 70 Uni-Bio Science Group Ltd. 71 ProStrakan Group plc 72 Teikoku Pharma USA, Inc. 73 SymBio Pharmaceuticals Limited 74 Cellerant Therapeutics, Inc. 75 Spectrum Pharmaceuticals, Inc. 76 INSYS Therapeutics, Inc. 77 Pharmagenesis, Inc. 78 Neurotune AG 79 Med Discovery SA 80 Helsinn Healthcare S.A. 81 Wellstat Therapeutics Corporation 82 Ventria Bioscience 83 PledPharma AB 84 Tranzyme Pharma, Inc. 85 Indus Biotech Private Limited 86 Synageva BioPharma Corp. 87 Phage Biotechnology Corporation 88 Inimex Pharmaceuticals, Inc. 89 Bolder Biotechnology, Inc. 90 Shin Nippon Biomedical Laboratories, Ltd. 91 Welichem Biotech Inc. 92 Sound Pharmaceuticals, Inc. 93 SpePharm Holding B.V. 94 Biothera 95 Avesthagen Limited 96 Spinifex Pharmaceuticals Pty Limited 97 Tosk, Inc. 98 Almac Discovery Ltd. 99 Pfenex Inc. 100 Mycenax Biotech Inc. 101 Therapure Biopharma Inc. 102 Eurofarma 103 Neumedicines Inc. 104 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 3/11
  • 4. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Applied Protein Sciences, LLC 105 Acacia Pharma Ltd. 106 Advancell 107 Chemotherapy Effects ' Therapeutics Assessment 108 Assessment by Monotherapy Products 108 Assessment by Combination Products 109 Assessment by Route of Administration 110 Assessment by Molecule Type 112 Drug Profiles 115 Romiplostim - Drug Profile 115 rolapitant hydrochloride - Drug Profile 117 MAXY-G34 - Drug Profile 118 sodium thiosulfate - Drug Profile 120 menadione - Drug Profile 122 ondansetron MR - Drug Profile 123 granisetron - Drug Profile 124 MDPK-67b - Drug Profile 125 NT-13317 - Drug Profile 127 ondansetron hydrochloride - Drug Profile 128 Multikine - Drug Profile 129 TZP-201 - Drug Profile 131 dronabinol - Drug Profile 132 Slow-Release G-CSF - Drug Profile 133 KRN-5500 - Drug Profile 134 NuPIAO - Drug Profile 136 granisetron - Drug Profile 137 granisetron - Drug Profile 138 (amitriptyline + ketamine) - Drug Profile 140 ondansetron CR - Drug Profile 141 ezatiostat hydrochloride - Drug Profile 142 Pegylated GCSF - Drug Profile 144 LG-631 - Drug Profile 145 filgrastim - Drug Profile 147 ZP-1846 - Drug Profile 148 PBI-1402 - Drug Profile 149 balugrastim - Drug Profile 150 INDUS-82020 - Drug Profile 152 leteprinim - Drug Profile 153 PHY-626 - Drug Profile 154 PHY-777 - Drug Profile 155 ErepoXen - Drug Profile 156 IMX-942 - Drug Profile 157 GCS-100 - Drug Profile 158 CLT-008 - Drug Profile 160 GranNEX - Drug Profile 161 granisetron - Drug Profile 162 Dexamethasone + Granisetron + Prochlorperazine - Drug Profile 163 F-511 cream - Drug Profile 165 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 4/11
  • 5. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! filgrastim - Drug Profile 166 pegfilgrastim - Drug Profile 167 levocarnitine - Drug Profile 168 buprenorphine hydrochloride - Drug Profile 169 pegfilgrastim - Drug Profile 170 MTP-131 - Drug Profile 171 lipegfilgrastim - Drug Profile 173 darbepoetin alfa - Drug Profile 174 LY-2787106 - Drug Profile 175 dexrazoxane - Drug Profile 176 palonosetron hydrochloride - Drug Profile 177 ATH-008 - Drug Profile 178 droperidol - Drug Profile 179 CR-3294 - Drug Profile 180 uridine triacetate - Drug Profile 181 TPW-146 - Drug Profile 183 EMA-401 - Drug Profile 184 SPI-1005 - Drug Profile 186 ebselen - Drug Profile 188 granisetron - Drug Profile 189 WBI-2100 + [cisplatin] - Drug Profile 190 WBI-2100 + [gemcitabine hydrochloride] - Drug Profile 191 WBI-2100 + [dacarbazine] - Drug Profile 192 WBI-2100 + [paclitaxel] - Drug Profile 193 (netupitant + palonosetron hydrochloride) - Drug Profile 194 NMIL12-1 - Drug Profile 196 dexamethasone acetate + [palonosetron hydrochloride] - Drug Profile 198 PanCyte - Drug Profile 199 erythropoietin biosimilar - Drug Profile 200 APD-403 - Drug Profile 201 NT-24336 - Drug Profile 202 UNI-rhIL-11 - Drug Profile 203 TBI-304 - Drug Profile 204 BBT-015 - Drug Profile 205 BBT-018 - Drug Profile 206 IRX-4310 - Drug Profile 207 Imprime PGG - Drug Profile 208 5HT3 receptor antagonist + [dexamethasone ] + [fosaprepitant dimeglumine] - Drug Profile 210 filgrastim - Drug Profile 211 aprepitant - Drug Profile 212 granisetron - Drug Profile 213 filgrastim - Drug Profile 215 darbepoetin alfa - Drug Profile 216 budesonide - Drug Profile 217 Plasmid Gene Therapy For Chemotherapy-Induced Thrombocytopenia - Drug Profile 218 carbamazepine - Drug Profile 219 Filgrastim Biosimilar - Drug Profile 220 F-627 - Drug Profile 221 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 5/11
  • 6. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! palonosetron hydrochloride New Formulation - Drug Profile 222 dronabinol Intavenous - Drug Profile 223 PLX-BMP - Drug Profile 224 calcitriol - Drug Profile 227 INT-0010 - Drug Profile 228 PLED-mangafodipir trisodium - Drug Profile 229 NN1 Neurotrophin - Drug Profile 231 erythromycin - Drug Profile 232 AK-295 - Drug Profile 233 NecroX-7 - Drug Profile 234 amisulpride - Drug Profile 235 VEN-101 - Drug Profile 236 TK-112690 - Drug Profile 237 filgrastim Biosimilar - Drug Profile 238 pegfilgrastim Biosimilar - Drug Profile 239 AP-002 - Drug Profile 240 Prostaglandin E2 - Drug Profile 241 TheraPhil - Drug Profile 242 PG2-2000 - Drug Profile 243 granisetron - Drug Profile 244 SHIP1 Inhibitors - Drug Profile 245 Apoptosis Inhibitors - Drug Profile 246 Chemotherapy Effects Therapeutics ' Drug Profile Updates 247 Chemotherapy Effects Therapeutics ' Discontinued Products 283 Chemotherapy Effects Therapeutics - Dormant Products 284 Chemotherapy Effects ' Product Development Milestones 288 Featured News & Press Releases 288 Appendix 294 Methodology 294 Coverage 294 Secondary Research 294 Primary Research 294 Expert Panel Validation 294 Contact Us 295 Disclaimer 295 List of Tables Number of Products Under Development for Chemotherapy Effects, H1 2013 20 Products under Development for Chemotherapy Effects ' Comparative Analysis, H1 2013 21 Number of Products under Development by Companies, H1 2013 23 Number of Products under Development by Companies, H1 2013 (Contd..1) 24 Number of Products under Development by Companies, H1 2013 (Contd..2) 25 Number of Products under Development by Companies, H1 2013 (Contd..3) 26 Number of Products under Development by Companies, H1 2013 (Contd..4) 27 Number of Products under Development by Companies, H1 2013 (Contd..5) 28 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 6/11
  • 7. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Number of Products under Investigation by Universities/Institutes, H1 2013 30 Comparative Analysis by Late Stage Development, H1 2013 31 Comparative Analysis by Mid Clinical Stage Development, H1 2013 32 Comparative Analysis by Early Clinical Stage Development, H1 2013 33 Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013 34 Products under Development by Companies, H1 2013 35 Products under Development by Companies, H1 2013 (Contd..1) 36 Products under Development by Companies, H1 2013 (Contd..2) 37 Products under Development by Companies, H1 2013 (Contd..3) 38 Products under Development by Companies, H1 2013 (Contd..4) 39 Products under Development by Companies, H1 2013 (Contd..5) 40 Products under Development by Companies, H1 2013 (Contd..6) 41 Products under Investigation by Universities/Institutes, H1 2013 42 Kyowa Hakko Kirin Co., Ltd., H1 2013 43 Amgen Inc., H1 2013 44 Adherex Technologies Inc., H1 2013 45 Eli Lilly and Company, H1 2013 46 BioDelivery Sciences International, Inc., H1 2013 47 Merck & Co., Inc., H1 2013 48 Lentigen Corporation, H1 2013 49 Reliance Life Sciences Pvt. Ltd., H1 2013 50 A.P. Pharma, Inc., H1 2013 51 Aphios Corporation, H1 2013 52 Axcan Pharma Inc., H1 2013 53 Dong-A Pharmaceutical Co., Ltd., H1 2013 54 Dr. Reddy's Laboratories Limited, H1 2013 55 Maxygen, Inc., H1 2013 56 Sigma-Tau S.p.A., H1 2013 57 Teva Pharmaceutical Industries Limited, H1 2013 58 Sandoz Inc., H1 2013 59 CEL-SCI Corporation, H1 2013 60 Zosano Pharma, Inc., H1 2013 61 3SBio Inc., H1 2013 62 EpiCept Corporation, H1 2013 63 Hana Biosciences, Inc., H1 2013 64 IntelGenx Technologies Corp., H1 2013 65 NovaDel Pharma, Inc., H1 2013 66 La Jolla Pharmaceutical Company, H1 2013 67 Telik, Inc., H1 2013 68 Mundipharma International Limited, H1 2013 69 Cerbios-Pharma SA, H1 2013 70 ProMetic Life Sciences Inc., H1 2013 71 Lipoxen PLC, H1 2013 72 LG Life Sciences, Ltd, H1 2013 73 Diamyd Medical AB, H1 2013 74 Pluristem Therapeutics Inc., H1 2013 75 DARA BioSciences, Inc., H1 2013 76 LTT Bio-Pharma Co., Ltd., H1 2013 77 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 7/11
  • 8. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Uni-Bio Science Group Ltd., H1 2013 78 ProStrakan Group plc, H1 2013 79 Teikoku Pharma USA, Inc., H1 2013 80 SymBio Pharmaceuticals Limited, H1 2013 81 Cellerant Therapeutics, Inc., H1 2013 82 Spectrum Pharmaceuticals, Inc., H1 2013 83 INSYS Therapeutics, Inc., H1 2013 84 Pharmagenesis, Inc., H1 2013 85 Neurotune AG, H1 2013 86 Med Discovery SA, H1 2013 87 Helsinn Healthcare S.A., H1 2013 88 Wellstat Therapeutics Corporation, H1 2013 89 Ventria Bioscience, H1 2013 90 PledPharma AB, H1 2013 91 Tranzyme Pharma, Inc., H1 2013 92 Indus Biotech Private Limited, H1 2013 93 Synageva BioPharma Corp., H1 2013 94 Phage Biotechnology Corporation, H1 2013 95 Inimex Pharmaceuticals, Inc., H1 2013 96 Bolder Biotechnology, Inc., H1 2013 97 Shin Nippon Biomedical Laboratories, Ltd., H1 2013 98 Welichem Biotech Inc., H1 2013 99 Sound Pharmaceuticals, Inc., H1 2013 100 SpePharm Holding B.V., H1 2013 101 Biothera, H1 2013 102 Avesthagen Limited, H1 2013 103 Spinifex Pharmaceuticals Pty Limited, H1 2013 104 Tosk, Inc., H1 2013 105 Almac Discovery Ltd., H1 2013 106 Pfenex Inc., H1 2013 107 Mycenax Biotech Inc., H1 2013 108 Therapure Biopharma Inc., H1 2013 109 Eurofarma, H1 2013 110 Neumedicines Inc., H1 2013 111 Applied Protein Sciences, LLC, H1 2013 112 Acacia Pharma Ltd., H1 2013 113 Advancell, H1 2013 114 Assessment by Monotherapy Products, H1 2013 115 Assessment by Combination Products, H1 2013 116 Assessment by Stage and Route of Administration, H1 2013 118 Assessment by Stage and Molecule Type, H1 2013 121 Chemotherapy Effects Therapeutics ' Drug Profile Updates 254 Chemotherapy Effects Therapeutics ' Discontinued Products 290 Chemotherapy Effects Therapeutics ' Dormant Products 291 Chemotherapy Effects Therapeutics ' Dormant Products (Contd..1) 292 Chemotherapy Effects Therapeutics ' Dormant Products (Contd..2) 293 Chemotherapy Effects Therapeutics ' Dormant Products (Contd..3) 294 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 8/11
  • 9. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! List of Figures Number of Products under Development for Chemotherapy Effects, H1 2013 20 Products under Development for Chemotherapy Effects ' Comparative Analysis, H1 2013 21 Products under Development by Companies, H1 2013 22 Products under Investigation by Universities/Institutes, H1 2013 29 Late Stage Products, H1 2013 31 Mid Clinical Stage Products, H1 2013 32 Early Clinical Stage Products, H1 2013 33 Discovery and Pre-Clinical Stage Products, H1 2013 34 Assessment by Monotherapy Products, H1 2013 115 Assessment by Combination Products, H1 2013 116 Assessment by Route of Administration, H1 2013 117 Assessment by Stage and Route of Administration, H1 2013 118 Assessment by Molecule Type, H1 2013 119 Assessment by Stage and Molecule Type, H1 2013 120 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 9/11
  • 10. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Chemotherapy Effects ' Pipeline Review, H1 2013 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 000.00 Quantity: _____ Site License--USD 4 000.00 Quantity: _____ Corporate License--USD 6 000.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 10/11
  • 11. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Chemotherapy Effects ' Pipeline Review, H1 2013 (From Slideshare) Page 11/11